Introduction:
The generic drug market in the USA has been experiencing steady growth in recent years, with an increasing emphasis on government procurement and tenders. According to the IMS Institute for Healthcare Informatics, generic drugs accounted for 89% of prescriptions dispensed in the USA in 2020. This trend is expected to continue as healthcare providers and government agencies seek cost-effective solutions to meet the growing demand for pharmaceuticals.
Top 10 Generic Drug Government Procurement & Tender Agencies in USA:
1. Department of Veterans Affairs (VA)
– The VA is one of the largest purchasers of generic drugs in the USA, with a procurement volume of over $4 billion in 2020. Their focus on providing affordable healthcare to veterans has made them a key player in the generic drug market.
2. Indian Health Service (IHS)
– The IHS plays a crucial role in providing healthcare services to Native American populations, with a procurement volume of $1.5 billion in generic drugs in 2020. Their commitment to improving access to affordable medications has made them a significant player in the market.
3. Department of Defense (DoD)
– The DoD is another major player in the generic drug procurement market, with a procurement volume of $3.2 billion in 2020. Their focus on ensuring the health and well-being of military personnel has led to a significant demand for generic medications.
4. Health Resources and Services Administration (HRSA)
– The HRSA is responsible for improving access to healthcare services for underserved populations, with a procurement volume of $900 million in generic drugs in 2020. Their efforts to expand access to affordable medications have made them a key player in the market.
5. Centers for Medicare & Medicaid Services (CMS)
– The CMS is a major purchaser of generic drugs for the Medicare and Medicaid programs, with a procurement volume of $2.5 billion in 2020. Their focus on providing cost-effective healthcare solutions for seniors and low-income populations has made them a significant player in the market.
6. National Institutes of Health (NIH)
– The NIH plays a crucial role in funding research and development for generic drugs, with a procurement volume of $700 million in 2020. Their investments in innovative treatments and therapies have contributed to the growth of the generic drug market.
7. Food and Drug Administration (FDA)
– The FDA plays a key role in regulating the approval and distribution of generic drugs in the USA. Their oversight ensures the safety and efficacy of generic medications, contributing to the overall growth of the market.
8. Department of Health and Human Services (HHS)
– The HHS is responsible for overseeing public health initiatives and programs, with a procurement volume of $1.8 billion in generic drugs in 2020. Their efforts to promote access to affordable medications have made them a significant player in the market.
9. Bureau of Primary Health Care (BPHC)
– The BPHC is focused on improving access to primary healthcare services for underserved populations, with a procurement volume of $600 million in generic drugs in 2020. Their commitment to expanding access to affordable medications has made them a key player in the market.
10. Department of Justice (DOJ)
– The DOJ plays a crucial role in enforcing regulations and laws related to the generic drug market, ensuring fair competition and consumer protection. Their efforts to combat fraud and abuse in the industry contribute to the overall growth and sustainability of the market.
Insights:
The USA generic drug market is expected to continue growing in the coming years, driven by increasing demand for cost-effective medications and government initiatives to expand access to healthcare services. According to a report by Grand View Research, the USA generic drug market is projected to reach $239.8 billion by 2028, with a CAGR of 8.9% from 2021 to 2028. This growth is likely to be fueled by the increasing prevalence of chronic diseases, rising healthcare costs, and efforts to improve healthcare access for underserved populations. As government procurement and tenders play a significant role in shaping the generic drug market, companies will need to adapt to changing regulations and market dynamics to capitalize on emerging opportunities.
Related Analysis: View Previous Industry Report
